Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

15.4K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.4K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

46
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
46
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

878
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
878
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

1.3K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.3K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

32
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
32
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rational design and synthesis of theophylline-based hybrids as bacterial DHFR inhibitors: integrating molecular modelling and ADME prediction with biological validation.

In silico pharmacology·2026
Same author

Insights from the molecular docking and simulation analysis of seocalcitol with ACE2 and vitamin D receptor.

Bioinformation·2026
Same author

Structure-Based Optimization of Triazole-Linked Sesamol Conjugates as Antifungal Agents Targeting CYP51 in <i>Candida albicans</i>.

ACS infectious diseases·2026
Same author

Harnessing Lactiplantibacillus plantarum as an anti-fungal candidate against drug resistant Candida albicans.

Molecular biology reports·2026
Same author

Gut microbiota and inflammatory bowel disease: mechanisms, clinical implications, and future directions.

Molecular biology reports·2025
Same author

A randomized control trial to assess the effectiveness of a brief educational intervention on colonoscopy preparation and experience in patients with inflammatory bowel disease.

BMC gastroenterology·2025

Related Experiment Video

Updated: Mar 29, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.8K

Bacteriocins as Potential Anticancer Agents.

Sumanpreet Kaur1, Sukhraj Kaur1

  • 1Department of Microbiology, Guru Nanak Dev University , Punjab, India.

Frontiers in Pharmacology
|December 1, 2015
PubMed
Summary

Bacteriocins, peptides from bacteria, show selective cancer cell killing potential. These novel agents offer a promising alternative to conventional chemotherapy, addressing toxicity and resistance issues in cancer treatment.

Keywords:
anticancerbacteriocincancercolicincytotoxicitymicrocinnisinpediocin

More Related Videos

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

14.2K
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

14.0K

Related Experiment Videos

Last Updated: Mar 29, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.8K
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

14.2K
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

14.0K

Area of Science:

  • Microbiology
  • Oncology
  • Biochemistry

Background:

  • Cancer is a leading global cause of death, with conventional chemotherapy facing challenges like non-specific toxicity and drug resistance.
  • There is a growing need for novel anti-cancer agents with improved efficacy and reduced side effects.

Purpose of the Study:

  • To review the therapeutic potential of bacteriocins as novel anti-cancer agents.
  • To provide an overview of cancer cell-specific cytotoxic bacteriocins, their mechanisms of action, and demonstrated efficacies.

Main Methods:

  • Literature review of experimental studies on bacteriocins and their anti-cancer activities.
  • Analysis of bacteriocin characteristics, including selective cytotoxicity and mode of action against cancer cell lines.

Main Results:

  • Bacteriocins, ribosomally-synthesized cationic peptides, exhibit selective cytotoxicity towards various cancer cell lines compared to normal cells.
  • Experimental studies indicate promising therapeutic potential for bacteriocins in cancer treatment.

Conclusions:

  • Bacteriocin-based therapies represent a promising avenue for developing new anti-cancer drugs.
  • Further investigation and clinical trials are warranted to explore the full potential of bacteriocins in oncology.